Burkett Financial Services »

Humacyte shares owned by Burkett Financial Services

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Burkett Financial Services from 13F filings

Historical chart of Burkett Financial Services investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Burkett Financial Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Burkett Financial Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $97 18 5.44
2024-06-30 $86 18 4.78

More positions owned by Burkett Financial Services

Schwab US Large Cap Growth ETF Equity (SCHG)
Schwab US Dividend Equity ETF Equity (SCHD)
Vanguard FTSE Developed Markets ETF Equity (VEA)
MSCI EAFA Hedged Dollar ETF Equity (DBEF)
Eagle Capital Select Equity ETF Equity (EAGL)
iShares MSCI Min Vol Emerging Markets ETF Equity (EEMV)
Calamos S&P Structured ALT ETF Equity
iShares S&P 400 Mid Index Equity (IJH)
iShares S&P 600 Small Cap Index Equity (IJR)
Vanguard Intermediate Treasury ETF Equity (VGIT)
Apple Equity (AAPL)
Microsoft Corp Equity (MSFT)
Schwab Mid Cap Blend ETF Equity (SCHM)
Schwab International Equity ETF Equity (SCHF)
Vanguard High Dividend Yield ETF Equity (VYM)

View all positions for Burkett Financial Services

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte